Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Oxygen Controllers in Preterm InfanTs

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Preterm infants with a gestational age (GA) at birth of 24 - 29+6/7 weeks~* Receiving invasive mechanical ventilation or non-invasive respiratory support (NCPAP or NIPPV)~* Receiving supplemental oxygen (defined as FiO2 ≥ 0.25) at the time of enrollment and for at least 18 hours during the previous 24 hours; Or a coefficient of variation in supplemental oxygen of ≥ 0.1 in the previous 24 hours.~* Expected to complete the 49-hour or 50-hour study period in the current form of respiratory support, i.e. invasive mechanical ventilation or non-invasive respiratory support~* Written informed parental consent must be present.~Exclusion Criteria:~* Major congenital anomalies~* Arterial hypotension requiring vasopressor therapy within 48 hours prior to enrollment.~* If the attending physician considers the infant not stable enough for a switch to another ventilator.

- Gender: ALL
- Minimum Age: None
- Maximum Age: 8 Weeks
- Healthy Volunteers: f

Study Arms:
- CLiO2 (Type: EXPERIMENTAL): Automated oxygen control by the CLiO2 algorithm
- Oxygenie (Type: EXPERIMENTAL): Automated oxygen control by the Oxygenie algorithm

Based on this trial design, predict the completion outcome and termination type (if applicable).